Share chart Nautilus Biotechnology, Inc.
Extended chart
Simple chart
About Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., компания, занимающаяся наукой о жизни, занимается разработкой платформы для количественной оценки и раскрытия сложности протеома человека. Она разрабатывает Nautilus Platform, платформу протеомики, которая включает в себя комплексное решение, состоящее из инструментов, расходных материалов и программного обеспечения для анализа. Штаб-квартира компании находится в Сиэтле, штат Вашингтон.Main settings
IPO date
2021-06-10
ISIN
US63909J1088
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 0 | 0 |
| P/BV | 1.01 | 9 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -25.82 | 0 |
| ROE | -29.86 | 0 |
| ROIC | -15.19 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.4326 | 10 |
| Debt/Ratio | 0.1256 | 10 |
| Debt/Equity | 0.163 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 0 | 0 |
| Yield Ebitda, % | -2957.81 | 0 |
| Yield EPS, % | 334.09 | 10 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 0.7321 $ | 0 $ | 0 $ | -0.01 % | 0 % | 0 % |
| Week | 0.8 $ | 0 $ | 0 $ | -8.5 % | 0 % | 0 % |
| Month | 0.713 $ | 0.6999 $ | 0.927 $ | 2.66 % | 0 % | 0 % |
| Three month | 1.5 $ | 0.6679 $ | 1.14 $ | -51.2 % | 0 % | 0 % |
| Half a year | 2.24 $ | 0.6679 $ | 2.17 $ | -67.32 % | 0 % | 0 % |
| Year | 2.69 $ | 0.6679 $ | 3.08 $ | -72.79 % | 0 % | 0 % |
| 3 years | 3.81 $ | 0.6679 $ | 4.52 $ | -80.79 % | 0 % | 0 % |
| 5 years | 0 $ | 0.6679 $ | 22.43 $ | 0 % | 0 % | 0 % |
| 10 years | 0 $ | 0.6679 $ | 22.43 $ | 0 % | 0 % | 0 % |
| Year to date | 1.76 $ | 0.6679 $ | 2.04 $ | -58.41 % | 0 % | 0 % |
Main owners
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Principal Healthcare Innovators ETF | 0.04021 | 618.5 | 0.35 |
| Future Tech ETF | 0.04021 | 426.34 | 0.35 |
| 0.04 | 522.42 | 0.35 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Sujal M. Patel | Co-Founder, CEO, President, Secretary & Director | 827.24k | 1975 (50 years) |
| Dr. Parag Mallick Ph.D. | Co-Founder, Chief Scientist & Director | 562.8k | 1977 (48 years) |
| Mr. Matthew B. Murphy ESQ. | General Counsel | 382.64k | 1965 (60 years) |
| Ms. Anna Mowry | CFO & Treasurer | 519.21k | 1984 (41 year) |
| Ms. Mary E. Godwin | Senior Vice President of Operations | N/A | 1959 (66 years) |
| Mr. Chris Blessington | Vice President of Corporate Marketing & Communications | N/A | |
| Mr. Nick A. Nelson | Chief Business Officer & Senior VP of Business Development | N/A | 1984 (41 year) |
| Dr. Subra Sankar Ph.D. | Senior Vice President of Product Development | 38.47k | 1959 (66 years) |
| Ms. Gwen E. Weld | Chief People Officer | 390.97k | 1958 (67 years) |
| Mr. Kentaro Suzuki | Chief Marketing Officer |
About company
Address: United States, Seattle. WA, 2701 Eastlake Avenue East - Open in google maps, Open in yandex maps
Website: https://www.nautilus.bio
Website: https://www.nautilus.bio
